COVID Symposium

Two mRNA COVID-19 Vaccines Advance in U.K. and U.S.

ASGCT Staff | December 03, 2020

A vaccine from Pfizer and BioNTech was approved this week for emergency use in the U.K., while the FDA will meet this month to discuss its emergency use authorization in the U.S. 

COVID Symposium
Read Full Story

COVID-19 Vaccine Candidates Show Gene Therapy is a Viable Strategy

ASGCT Staff | November 17, 2020

Findings from Moderna and Pfizer demonstrate that gene therapy is a viable strategy for developing vaccines to combat COVID-19.

COVID Symposium
Read Full Story

Day Two Highlights from the COVID 19 Symposium

ASGCT Staff | September 16, 2020

Catch up on highlights from the second day of ASGCT's COVD-19 Symposium.

COVID Symposium
Read Full Story

COVID Symposium Highlights the Hard Work Behind the Headlines

Emily Walsh Martin, Ph.D. | September 16, 2020

The much discussed COVID-19 Prevention Network slogan, "Hope is good. Help is better." really sums up the important work being done by the presenters at the ASGCT COVID-19 Symposium.

COVID Symposium
Read Full Story

Day One Highlights from the COVID-19 Symposium

ASGCT Staff | September 15, 2020

Catch up on highlights from the first day of ASGCT's COVD-19 Symposium.

COVID Symposium
Read Full Story

Fauci “Cautiously Optimistic” Regarding a COVID-19 Vaccine This Year

Edith Pfister, Ph.D. | September 15, 2020

Dr. Fauci told attendees he was “cautiously optimistic that we will have an answer by the end of 2020 and we’ll be able to start distributing vaccine in a meaningful way in 2021.”

COVID Symposium
Read Full Story
2021

ASGCT 24th Annual Meeting

May 11-14, 2021